All News
Did Your Specialty Choose You?
Why did I end up a rheumatologist? Circumstance, personality types, horoscopes or what? A current study in BMJ sheds light on why.
Read Article
Predicting Treatment Response in Inflammatory Muscle Disorders
MedPage Today
Rheumatologists looking for clues to whether their patients with certain inflammatory myopathies will improve on immunosuppressive drugs may find them in a new study appearing in Arthritis Care & Research.
Read Article
Doximity ranked 15 specialties w/ high telehealth adoption rates
1 Endocrinology
2 GI
3. Rheumatology
4 GU
5 Nephrology
6 Cardiology
7 ENT
8 Neuro
9 Allergy
10 Heme/Onc
11Family medicine
12 Dermatology
13 Geriatrics
14 Pulm
15 Psych https://t.co/d7xm1ovk15
Links:
Dr. John Cush RheumNow ( View Tweet)
Future considerations and treatment directions in systemic sclerosis per Dr Steen. #RWCS2022 @RWCSmtg https://t.co/FaJaJ9G5lU
Dr. John Cush RheumNow ( View Tweet)
Stem cell transplant has clear benefits on survival and skin thickening. #RWCS2022 @RWCSmtg https://t.co/UnGxLQzy0Q
Dr. John Cush RheumNow ( View Tweet)
GAVE - gastric antral vascular ectasia. AKA "watermelon stomach". Is pretty rare https://t.co/DcU0J2TNrN
Dr. John Cush RheumNow ( View Tweet)
Dr Steen's recipe to freaking with digital ulcers.#RWCS2022 @RWCSmtg https://t.co/VmDag701JC
Dr. John Cush RheumNow ( View Tweet)
Subsets of scleroderma defined by autoantibodies. #RWCS2022 @RWCSmtg https://t.co/ywe0yrHmWd
Dr. John Cush RheumNow ( View Tweet)
Many failed clinical trials in Scleroderma in the past. #RWCS2022 @RWCSmtg https://t.co/2PBfHAnqWu
Dr. John Cush RheumNow ( View Tweet)
Predicting Treatment Response in Inflammatory Muscle Disorders
Rheums looking for clues to whether their patients w/certain inflammatory myopathies will improve on immunosuppressive drugs may find them in a new study in Arthritis Care & Research.
https://t.co/kXFIEMTbkb https://t.co/UbO7nSsdAY
Links:
Dr. John Cush RheumNow ( View Tweet)
Significant mortality risk with scleroderma renal crisis. #RWCS2022 @RWCSmtg https://t.co/vIm0xDEjB3
Dr. John Cush RheumNow ( View Tweet)
Scleroderma ANA associations thru the ages. Dr. Virginia Steen
@RWCSmtg #RWCS2022 https://t.co/U64gpnCgS8
Dr. John Cush RheumNow ( View Tweet)
Would combination biologics work? Maybe according to this collection of antecdotal use. #RWCS2022 @RWCSmtg https://t.co/VJdINyqLQt
Dr. John Cush RheumNow ( View Tweet)
NOR-DRUM study shows that TDM, therapeutic drug monitoring, is beneficial. Study of RA, PSA, AS, Crohn's, UC Rheums don't do this, should they? #RWCS2022 @RWCSmtg https://t.co/Dc6mgr5jrL
Dr. John Cush RheumNow ( View Tweet)
IMPACT2 shows what we see in most PSA trials- little x-ray progression. #RWCS2022 @RWCSmtg https://t.co/uYXHB0s8g0
Dr. John Cush RheumNow ( View Tweet)
Dr Artie Kavanaugh presents comparison of targeted therapies in different inflammatory disorders. #RWCS2022 @RWCSmtg https://t.co/cX00RUOgAq
Dr. John Cush RheumNow ( View Tweet)
Fecal transplant (FMT) failed to help #PsA, small trial, unexpected result. #RWCS2022 @RWCSmtg https://t.co/zKq6FONuwk
Dr. John Cush RheumNow ( View Tweet)
Proposed new pathways involving the inhibition or deletion of kindlin-2, Stat3 and Runx2 in articular chondrocytes that promotes cartilage degradation and osteoarthritis -- potential new therapeutic target for OA https://t.co/EFgGctoYJY
Dr. John Cush RheumNow ( View Tweet)
Retrospective study of 98 patients with X-linked agammaglobulinemia (XLA) shows arthritis seen in 46% - more oligo- than polyarthritis, affecting . Knee, hip, and ankle. IVIG response rates around 70%; many w/ arthritis had missense mutation https://t.co/lreW5hkyr9
Links:
Dr. John Cush RheumNow ( View Tweet)
Voriconazole-induced synovitis, enthesitis and periostitis described in woman treated for invasive aspergillosis. She had polyarthralgias, synovitis (MRI and US), and periostitis on xray. Voriconazole prev. caused periostitis; now drug induced arthritis? https://t.co/10MnYvD3sA
Links:
Dr. John Cush RheumNow ( View Tweet)
